These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36119531)

  • 41. Irreversible Electroporation for Colorectal Liver Metastases.
    Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
    Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
    Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
    Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
    BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Safety and Efficacy of Nanosecond Pulsed Electric Field in Patients With Hepatocellular Carcinoma: A Prospective Phase 1 Clinical Study Protocol.
    Xu M; Xu D; Dong G; Ren Z; Zhang W; Aji T; Zhao Q; Chen X; Jiang T
    Front Oncol; 2022; 12():869316. PubMed ID: 35912221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Research Progress of Catheter-based Irreversible Electroporation for Tissue Ablation].
    Zhou Y; Han X; Ren F; Li Q; Chen X; Chu D; Wu R; Lyu Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Feb; 44(2):172-178. PubMed ID: 32400994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
    Dunki-Jacobs EM; Philips P; Martin RC
    Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of local failure after ultrasound guided irreversible electroporation of malignant liver tumors.
    Eisele RM; Chopra SS; Glanemann M; Gebauer B
    Interv Med Appl Sci; 2014 Dec; 6(4):147-53. PubMed ID: 25598987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a thermal model for irreversible electroporation: an approach to estimate and optimize the IRE protocols.
    Wardhana G; Almeida JP; Abayazid M; Fütterer JJ
    Int J Comput Assist Radiol Surg; 2021 Aug; 16(8):1325-1334. PubMed ID: 34032965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Irreversible Electroporation.
    Narayanan G
    Semin Intervent Radiol; 2015 Dec; 32(4):349-55. PubMed ID: 26622097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor Ablation Enhancement by Combining Radiofrequency Ablation and Irreversible Electroporation: An In Vitro 3D Tumor Study.
    Zhang B; Yang Y; Ding L; Moser MAJ; Zhang EM; Zhang W
    Ann Biomed Eng; 2019 Mar; 47(3):694-705. PubMed ID: 30565007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Irreversible electroporation in primary and metastatic hepatic malignancies: A review.
    Lyu T; Wang X; Su Z; Shangguan J; Sun C; Figini M; Wang J; Yaghmai V; Larson AC; Zhang Z
    Medicine (Baltimore); 2017 Apr; 96(17):e6386. PubMed ID: 28445252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initial experience with irreversible electroporation of liver tumours.
    Stillström D; Beermann M; Engstrand J; Freedman J; Nilsson H
    Eur J Radiol Open; 2019; 6():62-67. PubMed ID: 30723754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study.
    Niessen C; Igl J; Pregler B; Beyer L; Noeva E; Dollinger M; Schreyer AG; Jung EM; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2015 May; 26(5):694-702. PubMed ID: 25812712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys.
    Cornelis FH; Durack JC; Kimm SY; Wimmer T; Coleman JA; Solomon SB; Srimathveeravalli G
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1600-1608. PubMed ID: 28516273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
    Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
    J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.
    Fritz S; Sommer CM; Longerich T; Kuhn-Neureuther C; Radeleff B; Werner J; Hackert T
    Langenbecks Arch Surg; 2017 May; 402(3):465-473. PubMed ID: 28378237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Irreversible electroporation ablation for atrial fibrillation.
    Wojtaszczyk A; Caluori G; Pešl M; Melajova K; Stárek Z
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):643-651. PubMed ID: 29399927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biliary complications and efficacy after ablation of peribiliary tumors using irreversible electroporation (IRE) or radiofrequency ablation (RFA).
    Thamtorawat S; Patanawanitkul R; Rojwatcharapibarn S; Chaiyasoot W; Tongdee T; Yodying J; Sorotpinya S
    Int J Hyperthermia; 2022; 39(1):751-757. PubMed ID: 35649727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.
    Melenhorst MC; Scheffer HJ; Vroomen LG; Kazemier G; van den Tol MP; Meijerink MR
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):117-21. PubMed ID: 25994516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.